Health Care & Life Sciences » Biotechnology | Medpace Holdings Inc.

Medpace Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
272,890.00
326,428.00
359,059.00
421,582.00
436,152.00
704,589
Cost of Goods Sold (COGS) incl. D&A
178,918.00
260,759.00
272,186.00
307,585.00
307,937.00
527,860
Gross Income
93,972.00
65,669.00
86,873.00
113,997.00
128,215.00
176,729
SG&A Expense
35,109.00
39,668.00
56,998.00
61,507.00
63,357.00
75,681
EBIT
58,863.00
26,001.00
29,875.00
52,490.00
64,858.00
101,048
Unusual Expense
3,773.00
12,420.00
9,313.00
10,726.00
-
-
Non Operating Income/Expense
2,055.00
912.00
1,133.00
423.00
354.00
1,060
Interest Expense
18,000.00
26,457.00
27,259.00
19,384.00
7,559.00
8,157
Pretax Income
39,145.00
21,261.00
7,830.00
21,957.00
56,945.00
93,951
Income Tax
14,301.00
5,689.00
843.00
8,532.00
17,823.00
20,766
Consolidated Net Income
24,844.00
15,572.00
8,673.00
13,425.00
39,032.00
72,894
Net Income
24,844.00
15,572.00
8,673.00
13,425.00
39,032.00
72,894
Net Income After Extraordinaries
24,844.00
15,572.00
8,673.00
13,425.00
39,032.00
72,894
Net Income Available to Common
24,844.00
15,572.00
8,673.00
13,425.00
39,032.00
72,894
EPS (Basic)
0.61
0.38
0.21
0.37
0.98
1.97
Basic Shares Outstanding
40,692.10
40,692.10
40,692.10
35,690.00
39,056.00
35,547
EPS (Diluted)
0.61
0.38
0.21
0.37
0.98
1.97
Diluted Shares Outstanding
40,692.10
40,692.10
40,692.10
36,329.00
39,839.00
36,912
EBITDA
89,382.00
94,064.00
99,396.00
110,604.00
111,332.00
139,849
Other After Tax Income (Expense)
-
-
-
-
90.00
291

About Medpace Holdings

View Profile
Address
5375 Medpace Way
Cincinnati Ohio 45227
United States
Employees -
Website http://www.medpace.com
Updated 07/08/2019
Medpace Holdings, Inc. engages in the research, development, and trading of medical device and pharmaceutical products. Its services include medical affairs, clinical trial management, study feasibility, study-start-up, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.